All In Biotech

Drug Trial Radar · NCT01750190

A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Roxadustat (FG-4592) for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis

Last checked: Nov 19, 2026Latest source record: Oct 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 922 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

922

Actual

Start

Nov 5, 2012

Primary completion

Sep 24, 2018

Study completion Sep 24, 2018

Sponsor

Lead sponsor
Kyntra BioIndustry
Sponsor type
Industry
Collaborators
Astellas Pharma Europe B.V.; AstraZeneca
First posted
Dec 17, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether roxadustat is safe and effective in the treatment of anemia in participants with chronic kidney disease and not on dialysis.

Conditions

  • CKD Anemia

Interventions

  • RoxadustatDrug

    Oral tablets

  • PlaceboDrug

    Oral tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. United States (US FDA) Submission: Mean Change From Baseline in Hb (g/dL) Over Weeks 28 to 52 Regardless of Rescue TherapyTime frame: Baseline (Day 1, Week 0), Weeks 28 to 52
  2. Ex-US Submission: Number (%) of Participants Who Achieved a Hb Response During the First 24-Weeks of Treatment Censoring for Rescue TherapyTime frame: Baseline up to Week 24

Locations

145 sites in 16 countries. Site status is shown where the registry gives one.

  • Investigational Site

    Huntsville, Alabama

  • Investigational Site

    Tempe, Arizona

  • Investigational Site

    Alhambra, California

  • Investigational Site

    Chula Vista, California

  • Investigational Site

    Inglewood, California

  • Investigational Site

    La Mesa, California

  • Investigational Site

    La Palma, California

  • Investigational Site

    Lynwood, California

  • Investigational Site

    Northridge, California

  • Investigational Site

    Paramount, California

  • Investigational Site

    Riverside, California

  • Investigational Site

    Roseville, California

  • Investigational Site

    San Dimas, California

  • Investigational Site

    Whittier, California

  • Investigational Site

    Coral Gables, Florida

  • Investigational Site

    Cutler Bay, Florida

  • Investigational Site

    Hialeah, Florida

  • Investigational Site

    Miami, Florida

  • Investigational Site

    Miami, Florida

  • Investigational Site

    Miami, Florida

  • Investigational Site

    Miami, Florida

  • Investigational Site

    Ocala, Florida

  • Investigational Site

    Pembroke Pines, Florida

  • Investigational Site

    South Miami, Florida

  • Investigational Site

    Winter Park, Florida

  • Investigational Site

    Augusta, Georgia

  • Investigational Site

    Caldwell, Idaho

  • Investigational Site

    Shreveport, Louisiana

  • Investigational Site

    Baltimore, Maryland

  • Investigational Site

    Boston, Massachusetts

  • Investigational Site

    Detroit, Michigan

  • Investigational Site

    Flint, Michigan

  • Investigational Site

    Flint, Michigan

  • Investigational Site

    Pontiac, Michigan

  • Investigational Site

    Roseville, Michigan

  • Investigational Site

    St Louis, Missouri

  • Investigational Site

    New Brunswick, New Jersey

  • Investigational Site

    Albuquerque, New Mexico

  • Investigational Site

    Mineola, New York

  • Investigational Site

    The Bronx, New York

Showing 40 of 145 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.